Bring forth the synergy between biologists, medical scientists, data scientists and bioinformaticians
ImmunoMind (graduated from UC Berkeley SkyDeck) helps companies and medical centres design and produce safer and more effective CAR-T and other Cell Therapies, leveraging a proprietary multi-omics database of immune cells and AI. This collaboration connects eLabNext users to the ImmunoMind platform and enhances reporting in eLabJournal by using results from multi-omics-driven drug development and manufacturing. The ImmunoMind add-on identifies both cell subpopulations (e.g. Tscm, Tcm, Tem, Treg, NK, gdT cells) and their characteristics (e.g. exhaustion, senescence, activation) to create a comprehensive profile of CAR-T and other Cell Therapy products.
- The profile can help select the most effective design and dosage for CAR-T, improve QC and SOP to select T-cell subsets (such as Tscm and T-cell precursors), assess exhaustion and persistence of CAR-T cells in vitro and in vivo, and more.
- The platform supports Go/No-Go decision-making and reduces the risk of immunotherapy development and manufacturing.
Key Features & Benefits
Use Cases
More add-ons and integrations
Amass
Connect your experiments to the wider scientific evidence and decide what to test next
SciSure MCP
Connect the AI environment your organization chooses with permitted scientific information in SciSure.
BioSkepsis
Every experiment ends with one question: what to run next. BioSkepsis answers it inside SciSure, from what the published evidence actually shows, so your next move rests on the literature, not a hunch.
